M&A Deal Summary |
|
|---|---|
| Date | 2022-12-13 |
| Target | AMF Medical |
| Sector | Medical Products |
| Buyer(s) | Tandem Diabetes Care |
| Deal Type | Add-on Acquisition |
| Advisor(s) | Leerink Partners (Financial) Homburger (Legal) |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2006 |
| Sector | Medical Products |
| Employees | 2,650 |
| Revenue | 940M USD (2024) |
Tandem Diabetes Care is a developer of medical devices for the treatment of diabetes. Tandem Diabetes Care was founded in 2006 and is based in San Diego, California.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 3 |
| Sector: Medical Products M&A | 2 of 2 |
| Type: Add-on Acquisition M&A Deals | 3 of 3 |
| Country: Switzerland M&A | 1 of 1 |
| Year: 2022 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-07-21 |
Capillary Biomedical
Irvine, California, United States Capillary Biomedical is an infusion set developer. Infusion sets provide people flexible options in insulin pump wearability. Capillary Biomedical was founded in 2014 and is based in Irvine, California. |
Buy | - |